Rafferty Asset Management LLC
Legal Name: RAFFERTY ASSET MANAGEMENT, LLC
Full Contact Details
Rafferty Asset Management LLC
1301 AVENUE OF THE AMERICAS, 28TH FLOOR, NEW YORK, NY
646-572-3390
646-572-3498
Other Info
Rafferty Asset Management LLC, a New York-based Limited Liability Company, has been successfully registered with the US Securities and Exchange Commission since June 1997. With a total of 39 staff members, including 9 advisory personnel, the firm has remained approved with the SEC to continue its financial advisory services. Although the exact number of clients served is unspecified, the company's stable status within the industry still maintains its position as a trusted name in financial management.
Direct Owners
-
ANGELA MARY BRICKL
CHIEF COMPLIANCE OFFICER & GENERAL COUNSEL owns less than 5%
-
BARBARA RAFFERTY GRAT
MEMBER owns more than 10% but less than 25%
-
DANIEL DILLON O'NEILL
MEMBER owns less than 5%
-
LAWRENCE COLIN RAFFERTY
CHAIRMAN owns less than 5%
-
MINAKIAN PARTNERS, LLC
MEMBER owns more than 25% but less than 50%
-
PATRICK JAMES RUDNICK
CHIEF FINANCIAL OFFICER owns less than 5%
-
RAFFERTY HOLDINGS LLC
MEMBER owns more than 25% but less than 50%
-
ROBERT DAMIAN NESTOR
PRESIDENT owns less than 5%
-
GST FBO KATHLEEN RAFFERTY HAY & HEIRS
MEMBER owns more than 5% but less than 10%
-
GST FBO MICHAEL RAFFERTY & HEIRS
MEMBER owns more than 5% but less than 10%
Indirect Owners
-
DANIEL DILLON O'NEILL
MEMBER owns 75% or more
-
KATHLEEN RAFFERTY HAY
MEMBER owns more than 25% but less than 50%
-
LAWRENCE COLIN RAFFERTY
MEMBER owns more than 25% but less than 50%
-
MICHAEL LAWRENCE RAFFERTY
MEMBER owns more than 25% but less than 50%
-
JOSEPH PAUL CIPOLLA
OFFICER
-
RAFFERTY SERVICING, INC.
NON-MEMBER MANAGER
Firms Located Nearby
Top Holdings
- ADVANCED MICRO DEVICES INC $20,910k
- AFLAC INC $7,079k
- ACADIA PHARMACEUTCLS $5,380k
- ABBVIE INC $5,203k
- AGIOS PHARMACEUTICALS INC $4,504k
- ALEXANDRIA REAL ESTATE EQ IN $3,216k
- ACTIVISION BLIZZARD INC $2,504k
- ADOBE INC $2,337k
- Acceleron Pharma Inc $2,194k
- AIMMUNE THERAPEUTICS INC $1,974k